Niki BioSolutions, Inc. (NIKI) — Dilution Risk Analysis

Current Snapshot

Niki BioSolutions, Inc. (NIKI) has a DilutionWatch score of 50/10 and is classified as MEDIUM risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
34,280,137 Source

Dilution Risk Score

Score: 50/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

Recent filing forms in the source payload: 3 5, SC 13D 1, 6-K 1, XBRL 2.

FormFiledAccession
3 2026-08-13 0001213900-26-088803
3 2026-08-13 0001213900-26-089063
3 2026-07-28 0001213900-26-082351
3 2026-07-24 0001213900-26-081408
3 2026-07-24 0001213900-26-081412
SC 13D 2026-07-24 0001213900-26-081416
6-K 2026-06-10 0001213900-26-067085
xbrl 2026-02-28 xbrl-11770-xbrl_warrant
xbrl 2023-12-31 xbrl-11770-xbrl_convertible

Dilution Risk Drivers

DriverStored ValueSource
Cash runway 24 months Source

DilutionWatch Analysis

Risk Level
MEDIUM (Score: 50/10) Source
Cash Runway
24 months Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.